Merck & Co., Inc. Proceeds from Long-Term Debt Issued
Merck & Co., Inc. (MRK) reported Proceeds from Long-Term Debt Issued of $5.94 billion for the 12-month period ending 2023-12-31, per its 10-K filed 2024-02-26.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfLongTermDebt · last filed 2024-02-26
- Merck & Co., Inc. proceeds from issuance of long-term debt for the quarter ending 2023-12-31 was $0.00.
- Merck & Co., Inc. proceeds from issuance of long-term debt for the quarter ending 2023-09-30 was -$7.00M.
- Merck & Co., Inc. proceeds from issuance of long-term debt for the quarter ending 2022-12-31 was $0.00, a 100.00% decline year-over-year.
- Merck & Co., Inc. proceeds from issuance of long-term debt for the quarter ending 2022-09-30 was $0.00.
- Merck & Co., Inc. proceeds from issuance of long-term debt for fiscal 2023 was $5.94B.
- Merck & Co., Inc. proceeds from issuance of long-term debt for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- Merck & Co., Inc. proceeds from issuance of long-term debt for fiscal 2021 was $7.94B, a 79.59% increase from fiscal 2020.
- Merck & Co., Inc. proceeds from issuance of long-term debt for fiscal 2020 was $4.42B, a 10.87% decline from fiscal 2019.
| Period end | Proceeds from Issuance of Long-term Debt 3 month | Proceeds from Issuance of Long-term Debt 6 month | Proceeds from Issuance of Long-term Debt 9 month | Proceeds from Issuance of Long-term Debt 12 month |
|---|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26 | -$7.00M derived: sum of 2 quarters · filed 2024-02-26 | $5.94B 10-K · filed 2024-02-26 | |
| 2023-09-30 | -$7.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | $5.94B 10-Q · filed 2023-11-03 | ||
| 2023-06-30 | $5.95B 10-Q · filed 2023-08-07 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26 | $0.00 derived: sum of 2 quarters · filed 2024-02-26 | $0.00 10-K · filed 2024-02-26 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | $0.00 10-Q · filed 2023-11-03 | ||
| 2022-06-30 | $0.00 10-Q · filed 2023-08-07 | |||
| 2021-12-31 | $7.94B derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26 | $7.94B derived: sum of 2 quarters · filed 2024-02-26 | $7.94B 10-K · filed 2024-02-26 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | $0.00 10-Q · filed 2021-11-05 | ||
| 2021-06-30 | $0.00 10-Q · filed 2021-08-09 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24 | -$26.00M derived: sum of 2 quarters · filed 2023-02-24 | $4.42B derived: sum of 3 quarters · filed 2023-02-24 | $4.42B 10-K · filed 2023-02-24 |
| 2020-09-30 | -$26.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | $4.42B derived: sum of 2 quarters · filed 2021-11-05 | $4.42B 10-Q · filed 2021-11-05 | $4.42B derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-06-30 | $4.45B derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $4.45B 10-Q · filed 2021-08-09 | $4.45B derived: sum of 3 quarters · filed 2022-02-25 | $4.45B derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-03-31 | $0.00 10-Q · filed 2020-05-06 | $0.00 derived: sum of 2 quarters · filed 2022-02-25 | $0.00 derived: sum of 3 quarters · filed 2022-02-25 | $0.00 derived: sum of 4 quarters · filed 2022-02-25 |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $0.00 derived: sum of 2 quarters · filed 2022-02-25 | $0.00 derived: sum of 3 quarters · filed 2022-02-25 | $4.96B 10-K · filed 2022-02-25 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $0.00 derived: sum of 2 quarters · filed 2020-11-05 | $4.96B 10-Q · filed 2020-11-05 | $4.96B derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $4.96B 10-Q · filed 2020-08-05 | $4.96B derived: sum of 3 quarters · filed 2021-02-25 | $4.96B derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $4.96B 10-Q · filed 2020-05-06 | $4.96B derived: sum of 2 quarters · filed 2021-02-25 | $4.96B derived: sum of 3 quarters · filed 2021-02-25 | $4.96B derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $0.00 derived: sum of 2 quarters · filed 2021-02-25 | $0.00 derived: sum of 3 quarters · filed 2021-02-25 | $0.00 10-K · filed 2021-02-25 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $0.00 derived: sum of 2 quarters · filed 2019-11-05 | $0.00 10-Q · filed 2019-11-05 | |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $0.00 10-Q · filed 2019-08-06 | ||
| 2018-03-31 | $0.00 10-Q · filed 2019-05-08 | |||
| 2017-12-31 | $0.00 10-K · filed 2020-02-26 | |||
| 2016-12-31 | $1.07B derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $1.07B derived: sum of 2 quarters · filed 2019-02-27 | $1.08B derived: sum of 3 quarters · filed 2019-02-27 | $1.08B 10-K · filed 2019-02-27 |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | $8.00M derived: sum of 2 quarters · filed 2016-11-07 | $8.00M 10-Q · filed 2016-11-07 | $8.00M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-06-30 | $8.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | $8.00M 10-Q · filed 2016-08-08 | $8.00M derived: sum of 3 quarters · filed 2018-02-27 | $6.00M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-03-31 | $0.00 10-Q · filed 2016-05-09 | $0.00 derived: sum of 2 quarters · filed 2018-02-27 | -$2.00M derived: sum of 3 quarters · filed 2018-02-27 | -$3.00M derived: sum of 4 quarters · filed 2018-02-27 |
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | -$2.00M derived: sum of 2 quarters · filed 2018-02-27 | -$3.00M derived: sum of 3 quarters · filed 2018-02-27 | $7.94B 10-K · filed 2018-02-27 |
| 2015-09-30 | -$2.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | -$3.00M derived: sum of 2 quarters · filed 2016-11-07 | $7.94B 10-Q · filed 2016-11-07 | $11.08B derived: sum of 4 quarters · filed 2017-02-28 |
| 2015-06-30 | -$1.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | $7.94B 10-Q · filed 2016-08-08 | $11.09B derived: sum of 3 quarters · filed 2017-02-28 | $11.09B derived: sum of 4 quarters · filed 2017-02-28 |
| 2015-03-31 | $7.94B 10-Q · filed 2016-05-09 | $11.09B derived: sum of 2 quarters · filed 2017-02-28 | $11.09B derived: sum of 3 quarters · filed 2017-02-28 | $11.09B derived: sum of 4 quarters · filed 2017-02-28 |
| 2014-12-31 | $3.15B derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $3.15B derived: sum of 2 quarters · filed 2017-02-28 | $3.15B derived: sum of 3 quarters · filed 2017-02-28 | $3.15B 10-K · filed 2017-02-28 |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | $1.00M derived: sum of 2 quarters · filed 2015-11-05 | $1.00M 10-Q · filed 2015-11-05 | $1.00M derived: sum of 4 quarters · filed 2016-02-26 |
| 2014-06-30 | $1.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $1.00M 10-Q · filed 2015-08-06 | $1.00M derived: sum of 3 quarters · filed 2016-02-26 | $1.00M derived: sum of 4 quarters · filed 2016-02-26 |
| 2014-03-31 | $0.00 10-Q · filed 2015-05-07 | $0.00 derived: sum of 2 quarters · filed 2016-02-26 | $0.00 derived: sum of 3 quarters · filed 2016-02-26 | |
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | $0.00 derived: sum of 2 quarters · filed 2016-02-26 | $6.47B 10-K · filed 2016-02-26 | |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | $6.47B 10-Q · filed 2014-11-10 | ||
| 2013-06-30 | $6.47B 10-Q · filed 2014-08-07 | |||
| 2012-12-31 | $58.00M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $2.56B derived: sum of 2 quarters · filed 2015-02-27 | $2.56B 10-K · filed 2015-02-27 | |
| 2012-09-30 | $2.50B derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $2.50B 10-Q · filed 2013-11-07 | ||
| 2012-06-30 | $0.00 10-Q · filed 2013-08-07 | |||
| 2011-12-31 | $0.00 10-K · filed 2014-02-27 | |||
| 2010-12-31 | $1.99B derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | $1.99B derived: sum of 2 quarters · filed 2013-02-28 | $2.00B 10-K · filed 2013-02-28 | |
| 2010-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-08 | $5.30M 10-Q · filed 2010-11-08 | ||
| 2010-06-30 | $5.30M 10-Q · filed 2010-08-06 | |||
| 2009-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-28 | $0.00 derived: sum of 2 quarters · filed 2012-02-28 | $4.23B 10-K · filed 2012-02-28 | |
| 2009-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-08 | $4.23B 10-Q · filed 2010-11-08 | ||
| 2009-06-30 | $4.23B 10-Q · filed 2010-08-06 | |||
| 2008-12-31 | $0.00 10-K · filed 2010-03-01 | |||
| 2007-12-31 | $0.00 10-K · filed 2010-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |